Profile data is unavailable for this security.
About the company
JiangXi Tianxin Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of monomeric vitamin products. The Company's main products include vitamin B6, vitamin B1, biotin, folic acid, vitamin D3, ascorbyl palmitate, vitamin E powder, etc. Its products are mainly used in the fields of feed, medicine and food. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)2.01bn
- Net income in CNY557.43m
- Incorporated2004
- Employees2.47k
- LocationJiangXi Tianxin Pharmaceutical Co LtdLe'anjiang Industrial Park, Leping CityJINGDEZHEN 333300ChinaCHN
- Phone+86 7 986709288
- Fax+86 7 986702388
- Websitehttp://www.txpharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liaoning Chengda Biotechnology Co Ltd | 1.72bn | 332.10m | 11.36bn | 1.73k | 33.96 | 1.19 | -- | 6.61 | 0.8032 | 0.8032 | 4.16 | 22.93 | 0.1702 | 0.763 | 1.43 | 991,973.80 | 3.29 | 10.63 | 3.41 | 11.01 | 80.53 | 85.74 | 19.33 | 39.56 | 17.44 | -- | 0.0018 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
| KPC Pharmaceuticals Inc | 7.55bn | 446.07m | 11.51bn | 5.05k | 25.66 | 2.08 | -- | 1.52 | 0.5924 | 0.5924 | 10.03 | 7.31 | 0.7819 | 2.75 | 2.56 | 1,494,697.00 | 4.64 | 5.42 | 7.75 | 9.13 | 40.84 | 43.68 | 5.94 | 5.70 | 1.51 | -- | 0.172 | 35.75 | -6.99 | 1.64 | 16.05 | 5.79 | -21.33 | 14.87 |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 2.01bn | 557.43m | 12.07bn | 2.47k | 21.68 | 2.71 | -- | 6.01 | 1.27 | 1.27 | 4.58 | 10.18 | 0.3977 | 2.75 | 10.26 | 812,720.60 | 11.04 | -- | 11.82 | -- | 41.64 | -- | 27.76 | -- | 6.39 | -- | 0.0234 | -- | -18.34 | -- | -23.51 | -- | -- | -- |
| Tibet Rhodiola Pharmaceutical Holding Co | 2.94bn | 737.44m | 12.16bn | 601.00 | 14.63 | 3.35 | -- | 4.13 | 2.58 | 2.58 | 9.69 | 11.26 | 0.6264 | 1.54 | 6.79 | 4,894,779.00 | 15.80 | 12.44 | 20.83 | 15.71 | 93.36 | 90.51 | 25.22 | 20.43 | 3.44 | 7.74 | 0.1264 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.56bn | 675.80m | 12.16bn | 2.53k | 17.86 | 4.20 | -- | 3.41 | 1.20 | 1.20 | 6.34 | 5.10 | 0.7489 | 2.24 | 10.18 | 1,408,620.00 | 14.20 | 10.68 | 23.52 | 16.56 | 72.35 | 74.42 | 18.96 | 14.92 | 0.9579 | -- | 0.0073 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.46bn | 486.79m | 12.21bn | 8.41k | 24.85 | 1.83 | -- | 1.89 | 0.1912 | 0.1912 | 2.54 | 2.59 | 0.618 | 2.39 | 4.56 | 768,224.60 | 4.98 | 6.77 | 6.93 | 10.50 | 51.47 | 63.24 | 8.06 | 11.10 | 1.24 | -- | 0.0781 | 42.32 | 12.20 | -0.8267 | 65.20 | -6.21 | -11.64 | 5.92 |
| BrightGene Bio-Medical Technology Co Ltd | 1.24bn | 188.08m | 12.70bn | 1.16k | 67.31 | 5.39 | -- | 10.23 | 0.4466 | 0.4466 | 2.96 | 5.57 | 0.2522 | 1.63 | 3.50 | 1,074,862.00 | 2.91 | 6.53 | 3.57 | 7.93 | 54.97 | 56.93 | 11.55 | 19.90 | 1.18 | 4.53 | 0.4841 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
Data as of Nov 01 2024. Currency figures normalised to JiangXi Tianxin Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Caitong Fund Management Co., Ltd.as of 30 Sep 2023 | 1.46m | 0.99% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 689.19k | 0.47% |
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 560.00k | 0.38% |
| Orient Securities Asset Management Co. Ltd.as of 30 Sep 2023 | 547.90k | 0.37% |
| GF Fund Management Co., Ltd.as of 22 Jan 2024 | 397.80k | 0.27% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 346.87k | 0.24% |
| Taikang Fund Management Co. Ltd.as of 30 Sep 2023 | 280.20k | 0.19% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 180.00k | 0.12% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 174.17k | 0.12% |
| Nuode Asset Management Co., Ltd.as of 30 Jun 2024 | 164.66k | 0.11% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
